Novo Licenses Orbis Oral Macrocycle Discovery

Company Orbis Medicines / Novo Nordisk Event Type Discovery and License Collaboration Modality Oral Synthetic Macrocycles Asset nGen Platform (Undisclosed Cardiometabolic Targets) Target Undisclosed Disease Area Cardiometabolic Disease Summary Orbis Medicines and Novo Nordisk entered a multi-target discovery and license collaboration for orally bioavailable synthetic…